Aparicio Serrano, AnaGallego Jimenez, ElmaCastro Rodriguez, JavierSoto Escribano, PilarIglesias Flores, EvaMarin Pedrosa, SandraBenitez, Jose Manuel2023-05-032023-05-032022Serrano AA, Jiménez EG, Rodríguez JC, Escribano PS, Flores EI, Pedrosa SM, et al. Mesalazine induced interstitial pneumonitis in the COVID era. Revista Española de Enfermedades Digestivas [Internet]. 1 de enero de 20221130-0108http://hdl.handle.net/10668/21728Mesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC). Drug-induced hypersensitivity pneumonitis is considered very rare (< 1/10 000 patients).enMesalazineLung injuryUlcerative colitisAnti-inflammatory agents, non-steroidalCOVID-19Colitis, ulcerativeHumansLung diseases, interstitialMesalamineresearch article35199533open accessAlveolitis alérgica extrínsecaColitis ulcerosaMantenimientoMesalaminaPacientesPreparaciones farmacéuticas10.17235/reed.2022.8635/2021https://online.reed.es/DOI/PDF/ArticuloDOI_8635.pdf